Adrenal incidentaloma

Current Opinion in Oncology

Volumn 15, Issue 1, 2003, Pages 84-90

  Thompson, Geoffrey B ^a,b   Young Jr , William F ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; HYDROXYPROGESTERONE; IODOCHOLESTEROL; STEROID 21 MONOOXYGENASE;

ADRENAL BIOPSY; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX TUMOR; ADRENALECTOMY; ADULT; AGED; CANCER SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL ADRENAL HYPERPLASIA; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ENDOCRINE TUMOR; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROCORTISONE BLOOD LEVEL; LABORATORY TEST; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PHEOCHROMOCYTOMA; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; TUMOR VOLUME;

ADRENAL GLAND NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MIDDLE AGED;

EID: 0037252556     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200301000-00013     Document Type: Review

References (57)

1. Kepler EJ, Keating FR: Diseases of the adrenal glands: tumors of the adrenal cortex, diseases of the adrenal medulla and allied disturbances. Arch Intern Med 1941, 68:1010.
2. Kloos RT, Gross MD, Francis IR, et al.: Incidentally discovered adrenal masses. Endocr Rev 1995, 16:460-484.
3. Russell RP, Masi AT, Richter ED: Adrenal cortical adenomas and hypertension: a clinical pathologic analysis of 690 cases with matched controls and a review of the literature. Medicine (Baltimore) 1972, 51:211-225.
4. Commons RR, Callaway CP: Adenomas of the adrenal cortex. Arch Intern Med 1948, 81:37.
5. Devenyi I: Possibility of normokalaemic primary aldosteronism as reflected in the frequency of adrenal cortical adenomas. J Clin Pathol 1967, 20:49-51.
6. Kokko JP, Brown TC, Berman MM: Adrenal adenoma and hypertension. Lancet 1967, 1:468-470.
7. Young WF Jr: Management approaches to adrenal incidentalomas. Endocrinol Metab Clin North Am 2000, 29:159-185.
8. Barzon L, Scaroni C, Soninon N, et al.: Incidentally discovered adrenal tumors: Endocrine and scintigraphic correlates. J Clin Endorinol Metab 1998, 83:55-62.
9. Bastounis EA, Karayiannakis AJ, Anapliotou ML, et al.: Incidentalomas of the adrenal gland: diagnostic and therapeutic implications. Am Surg 1997, 63:356-360.
10. Bondanelli M, Campo M, Trasforini G, et al.: Evaluation of hormonal function in a series of incidentally discovered adrenal masses. Metabolism 1997, 46:107-113.
11. Caplan RH, Strutt PJ, Wickus GG: Subclinical hormone secretion by incidentally discovered adrenal masses. Arch Surg 1994, 129:291-296.
12. Herrera MF, Grant CS, van Heerden JA, et al.: Incidentally discovered adrenal tumors: an institutional perspective. Surgery 1991, 110:1014-1021.
13. Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J, et al.: Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol 1997, 46:29-37.
14. Linos DA, Stylopoulos N, Raptis SA: Adrenaloma: a call for more aggressive management. World J Surg 1996, 20:788-792.
15. Mantero F, Masini AM, Opocher G, et al.: Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. Horm Res 1997, 47:284-289.
16. Osella G, Terzolo M, Borretta G, et al.: Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J Clin Endocrinol Metab 1994, 79:1532-1539.
17. Proye C, Manjili MJ, Combemale F, et al.: Experience gained from operation of 103 adrenal incidentalomas. Lagenbecks Arch Surg 1998, 383:330-338.
18. Murai M, Baba S, Nakashima J, et al.: Management of incidentally discovered adrenal masses. World J Urol 1999, 17:9-14.
19. Tütüncü NB, Gedik O: Adrenal incidentalomas: report of 33 cases. J Surg Oncol 1999, 70:247-250.
20. Virkkala A, Valimaki M, Pelkonen R, et al.: Endocrine abnormalities in patients with adrenal tumors incidentally discovered on computed tomography. Acta Endocrinol 1989, 121:67-72.
21. Bertherat J, Mosnier-Pudar H, Bertagna X: Adrenal incidentalomas. Curr Opin Oncol 2002, 14:58-63.
22. Weinstein LS, Shenker A, Gejman PV, et al.: Activating mutations of the stimulatory G protein in the McCune-Albright. N Engl J Med 1991, 325:1688-1695.
23. Gicquel C, Raffin-Sanson ML, Gaston V, et al.: Structural and functional abnormalities at the 11 p15 are associated with malignant phenotype: study on a sedes of 82 adrenocortical tumors. J Clin Endocrinol Metab 1997, 82:2559-2564.
24. Gicquel C, Bertherat J, Le Bouc Y, et al.: Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms. Endocrinol Metab Clin North Am 2000, 29:1-13.
25. Kolomecki K, Stepien H, Bartos M, et al.: Usefulness of BEGF, MMP-2,MMP-3, and TIMP-2 serum level evaluation in patients with adrenal tumors. Endocr Regul 2001, 35:9-16. Metalloproteases and vascular endothelial growth factor serum levels are significantly higher in malignant incidentalomas and may prove useful as tumor markers.
26. Kolomecki K, Stepien H, Bartos M, et al.: Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery. Neoplasma 2001, 48:116-121.
27. Charbonnel B, Chatal JF, Ozanne P: Does the corticoadrenal adenoma with pre-Cushing's syndrome exist? J Nucl Med 1981, 22:1059-1061.
28. Midorikawa S, Sanada H, Hashimoto S, et al.: The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol 2001, 54:797-804. Insulin resistance may be a subtle finding in patients with adrenal incidentaloma and should be evaluated in deciding whether to remove tumor by surgery.
29. Osella G, Reimondo G, Peretti P, et al.: The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis. J Clin Endocrinol Metab 2001, 86:604-607. Glucocorticoid excess associated with adrenal incidentaloma does not increase the risk of osteoporosis in this one study.
30. Tanabe A, Naruse M, Nishikawa T, et al.: Autonomy of cortisol secretion in clinically silent adrenal incidentaloma. Horm Metab Res 2001, 33:444-450. The incidence of autonomous cortisol production by adrenal incidentaloma is not insignificant in this study.
31. Terzolo M, Pia A, Ali A, et al.: Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002, 87:998-1003. The slight hypercortisolism observed in this cohort may contribute significantly to insulin resistance and may be a new cause of the metabolic syndrome.
32. Garrapa GGM, Pantanetti P, Arnaldi G, et al.: Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J Clin Endocrinol Metab 2001, 86:5301-5306. Subtle cortisol hypersecretion is probably present in adrenal incidentaloma and may be a factor promoting abnormal metabolic parameters and body composition.
33. Ozgen AG, Bayraktar F, Yilmaz C: Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma. Endocr Pract 2001, 7:448-453. Enzyme defects may play an important role in adrenal incidentalomas.
34. Midorikawa S, Sanada H, Hashimoto S, et al.: Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes. Endocr J 2001, 48:167-174.
35. Barzon L, Fallo F, Soninon N, et al.: Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002, 146:61-66. The risk of progression of SCS to overt Cushing is not low.
36. Osella G, Terzolo M, Reimondo G, et al.: Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 1997, 82:3303-3307.
37. Kudva C, Young WF Jr, Thompson GB, et al.: Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. Endocrinologist 1999, 9:77-80.
38. Kudva YC, Young WF Jr: Sensitivity of 24-hour urine metanephrines and fractionated catecholamines in benign sporadic adrenal pheochromocytoma [abstract OR289-5]. In Program and Abstracts of the 79th Annual Meeting of the Endocrine Society. Minneapolis, MN. Bethesda: The Endocrine Society Press; 1997:106.
39. Lim PO, Rodgers P, Cardale K, et al.: Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 1999, 353:40.
40. Young WF Jr: Phaechromocytoma: how to catch a moonbeam in your hands. Eur J Endocrinol 1997, 136:28.
41. Gordon RD, Stowasser M, Tunny TJ, et al.: High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994, 21:315-318.
42. Henley DJ, van Heerden JA, Grant CS, et al.: Adrenal cortical carcinoma: a continuing challenge. Surgery 1983, 94:926-931.
43. Wooten MD, King DK: Adrenal cortical carcinoma: epidemiology and treatment with mitotane and a review of the literature. Cancer 1993, 72:3145-3155.
44. Yamakita N, Saitoh M, Mercado-Asis LB, et al.: Asymptomatic adrenal tumor: 386 cases in Japan including our 7 cases. Endocr J 1990, 37:671-684.
45. Hofle G, Gasser RW, Lhotta K, et al.: Adrenocortical carcinoma evolving after diagnosis of preclinical Cushing's syndrome in an adrenal incidentaloma: a case report. Horm Res 1998, 50:237-242
46. Icard P, Chapuis Y, Andreassian B, et al.: Adrenocortical carcinoma in surgically treated patients: a retrospective study on 16 cases by the French Association of Endocrine Surgery. Surgery 1992, 112:972-979.
47. Kloos RT, Korobkin M, Thompson NW, et al.: Incidentally discovered adrenal masses. In Endocrine Neoplasms. Edited by Arnold A. Boston: Kluwer Academic; 1997:263.
48. Fishman EK, Deutch BM, Hartman DS, et al.: Primary adrenocortical carcinoma: CT evaluation with clinical correlation. AJR Am J Roentgenol 1987, 148:531-535.
49. Angeli A, Osella G, Ali A, et al.: Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res 1997, 47:279-283.
50. Falke THM, Sandler MP: Classification of silent adrenal masses: time to get practical. J Nucl Med 1994, 35:1152-1154.
51. Kebebew E, Siperstein AE, Duh Q-Y: Laparoscopic adrenalectomy: the optimal surgical approach. J Laparoendosc Adv Surg Tech 2001, 11:409-413. Laparoscopic adrenalectomy is safe and is associated with best patient outcomes.
52. Lezoche E, Guerrieri M, Felciotti F, et al.: Anterior, lateral, and posterior retroperitoneal approaches to endoscopic adrenalectomy. Surg Endosc 2002, 16:96-99. The transperitoneal approach requires the surgeon to be skilled in advanced laparoscopic surgery.
53. Gill IS: The case for laparoscopic adrenalectomy. J Urol 2001, 166:429-436.
54. Miccoli P, Raffaelli M, Berti P, et al.: Adrenal surgery before and after the introduction of laparoscopic adrenalectomy. Br J Surg 2002, 89:779-782.
55. Thompson GB, Grant CS, Schlinkert RT, et al.: Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery 1997, 122:1132-1136.
56. Brunt LM, Moley JF: Adrenal incidentaloma. World J Surg 2001, 25:905-913. The indications for adrenalectomy in patients with nonfunctioning adrenal tumors should not be liberalized because of the laparoscopic approach.
57. Young JA, Chapman WH III, Kim VB, et al.: Robotic-assisted adrenalectomy for adrenal incidentaloma: case and review of the technique. Surg Laparosc Endosc Percutan Tech 2002, 12:126-130. Robotic-assisted adrenalectomy may simplify laparoscopic adrenalectomy.